| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12098-016-2035-0 |
| P698 | PubMed publication ID | 26872684 |
| P2093 | author name string | Ratna Dua Puri | |
| P2860 | cites work | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 |
| Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing Variants. | Q35716022 | ||
| Whole-genome sequencing for optimized patient management | Q35857612 | ||
| Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth | Q36292736 | ||
| The usefulness of whole-exome sequencing in routine clinical practice. | Q50657606 | ||
| Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders. | Q50967429 | ||
| ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing | Q57642222 | ||
| Targeted Next Generation Sequencing Identifies a Novel Deletion in LAMA2 Gene in a Merosin Deficient Congenital Muscular Dystrophy Patient | Q85445096 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 281-282 | |
| P577 | publication date | 2016-02-13 | |
| P1433 | published in | Indian Journal of Pediatrics | Q26842079 |
| P1476 | title | Next Generation Sequencing in the Clinic | |
| P478 | volume | 83 |
| Q54090777 | Novel LAMA2 Gene Mutations Associated with Merosin-Deficient Congenital Muscular Dystrophy | cites work | P2860 |
Search more.